SB290157 trifluoroacetate

N.º de catálogoS8931 Lote:S893101

Imprimir

Datos técnicos

Fórmula

C24H29F3N4O6

Peso molecular 526.51 Número CAS 1140525-25-2
Solubilidad (25°C)* In vitro DMSO 100 mg/mL (189.92 mM)
Ethanol 100 mg/mL (189.92 mM)
Water Insoluble
In vivo (Agregue los solventes al producto individualmente y en orden.)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O

Validado por los laboratorios Selleck. Si necesita ajustes en esta formulación, póngase en contacto con nuestro equipo de ventas para pruebas personalizadas.

5.000mg/ml (9.50mM) Taking the 1 mL working solution as an example, add 50 μL of 100 mg/m clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify it; then continue to add 500 μL ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml significa ligeramente soluble o insoluble.
* Tenga en cuenta que Selleck prueba la solubilidad de todos los compuestos internamente, y la solubilidad real puede diferir ligeramente de los valores publicados. Esto es normal y se debe a ligeras variaciones entre lotes.
* Envío a temperatura ambiente (Las pruebas de estabilidad demuestran que este producto se puede enviar sin medidas de refrigeración.)

Preparación de soluciones madre

Actividad biológica

Descripción SB290157 trifluoroacetate (SB 290157 TFA) es un antagonista potente, competitivo y selectivo del receptor C3a (C3aR) con una IC50 de 200 nM para RBL-C3aR.
Objetivos
RBL-C3aR
(Cell-free assay)
200 nM
In vitro

SB 290157 functions as a competitive antagonist of 125I-C3a radioligand binding to rat basophilic leukemia (RBL)-2H3 cells expressing the human C3aR (RBLC3aR), with an IC50 of 200 nM. SB 290157 is a functional antagonist, blocking C3a-induced C3aR internalization in a concentration-dependent manner and C3a-induced Ca21 mobilization in RBL-C3aR cells and human neutrophils with IC50s of 27.7 and 28 nM, respectively. SB 290157 is selective for the C3aR in that it does not antagonize the C5aR or six other chemotactic G protein-coupled receptors. Functional antagonism is not solely limited to the human C3aR; SB 290157 also inhibits C3ainduced Ca21 mobilization of RBL-2H3 cells expressing the mouse and guinea pig C3aRs. It potently inhibits C3a-mediated ATP release from guinea pig platelets and inhibits C3a-induced potentiation of the contractile response to field stimulation of perfused rat caudal artery.

In vivo

In animal models, SB 290157, inhibits neutrophil recruitment in a guinea pig LPS-induced airway neutrophilia model and decreases paw edema in a rat adjuvant-induced arthritis model.

Protocolo (de referencia)

Ensayo celular:

[1]

  • Líneas celulares

    RBL-2H3 cells, HMC-1 cells

  • Concentraciones

    100 nM to 10 μM

  • Tiempo de incubación

    45 min

  • Método

    2–5 × 105 RBL-C3aR cells are incubated with 100 pM 125I-C3a and varying concentrations of antagonist at room temperature in 20 mM HEPES (pH 7.4), 125 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 0.25% BSA and 0.5 mM glucose (HAG-CM) for 45 min at room temperature. The unbound ligand is removed by vacuum filtration using the HV Millipore MultiScreen assay plate with a Durapore 0.45-mm pore size membrane equilibrated with HAG-CM. Filters are washed twice with 100 ml/well HAG-CM and dried. Plates are counted on a Beckman gamma counter 5500B.

Estudio en animales:

[1]

  • Modelos animales

    Male Hartley guinea pigs, 6–8 week old male Lewis rats

  • Dosificaciones

    30 mg/kg, 10 mg/kg, 3 mg/kg

  • Administración

    IP

Referencias

  • https://pubmed.ncbi.nlm.nih.gov/11342658/

Selleck's SB290157 trifluoroacetate Ha sido citado por 16 Publicaciones

Neuropeptide Precursor VGF Promotes Liver Metastatic Colonization of Gαq Mutant Uveal Melanoma by Facilitating Tumor Microenvironment via Paracrine Loops [ Advanced Science, October 18, 2024, e2407967] PubMed: nan
Impact of astrocytic C3-production on neuronal mitochondrial dysfunction in tauopathy mouse models [ bioRxiv, November 30, 2024, nan] PubMed: nan
Complement C3/C3aR Signaling Pathway Inhibition Ameliorates Retinal Damage in Experimental Retinal Vein Occlusion [ Investigative Ophthalmology & Visual Science, May 1, 2025, 2] PubMed: 40310626
The C3-C3aR axis drives rotenone-induced cognitive damage via synaptic engulfment, dark microglia and PANoptosis [ Redox Biology, January 30, 2026, 104062] PubMed: nan
The C3–C3aR axis drives rotenone-induced cognitive damage via synaptic engulfment, dark microglia and PANoptosis [ Redox Biology, January 30, 2026, 104062] PubMed: 41637879
Complement C3a receptor inactivation attenuates retinal degeneration induced by oxidative damage [ Frontiers in Neuroscience, August 30, 2022, 951491] PubMed: 36110094
The C3-C3aR axis drives rotenone-induced cognitive damage via synaptic engulfment, dark microglia and PANoptosis [ Redox Biol, 2026, 90:104062] PubMed: 41637879
C3/C3aR Bridges Spinal Astrocyte‐Microglia Crosstalk and Accelerates Neuroinflammation in Morphine‐Tolerant Rats [ CNS Neuroscience & Therapeutics, 2025, e70216] PubMed: 39801259
C3/C3aR Bridges Spinal Astrocyte-Microglia Crosstalk and Accelerates Neuroinflammation in Morphine-Tolerant Rats [ CNS Neurosci Ther, 2025, 31(1):e70216] PubMed: 39801259
Complement C3/C3aR Signaling Pathway Inhibition Ameliorates Retinal Damage in Experimental Retinal Vein Occlusion [ Investigative Ophthalmology & Visual Science, 2025, 2] PubMed: 40310626

POLÍTICA DE DEVOLUCIÓN
La Política de Devolución Incondicional de Selleck Chemical garantiza una experiencia de compra en línea fluida para nuestros clientes. Si no está satisfecho con su compra de alguna manera, puede devolver cualquier artículo(s) dentro de los 7 días posteriores a su recepción. En caso de problemas de calidad del producto, ya sean problemas relacionados con el protocolo o con el producto, puede devolver cualquier artículo(s) dentro de los 365 días a partir de la fecha de compra original. Siga las instrucciones a continuación al devolver productos.

ENVÍO Y ALMACENAMIENTO
Los productos Selleck se transportan a temperatura ambiente. Si recibe el producto a temperatura ambiente, tenga la seguridad de que el Departamento de Inspección de Calidad de Selleck ha realizado experimentos para verificar que la colocación a temperatura normal durante un mes no afectará la actividad biológica de los productos en polvo. Después de la recogida, guarde el producto de acuerdo con los requisitos descritos en la hoja de datos. La mayoría de los productos Selleck son estables en las condiciones recomendadas.

NO PARA USO HUMANO, DIAGNÓSTICO VETERINARIO O TERAPÉUTICO.